Auteur
Tasmina Goraya

Tasmina Goraya, PhD

Associé

Read More
Auteur
Tasmina Goraya

Tasmina Goraya, PhD

Associé

Read More

31 août 2018

Update on surgical meshes

  • Quick read

In March 2018, we reported on an announcement by the UK Government to review three NHS treatments: the hormone pregnancy test Primodos, sodium valproate and the use of vaginal meshes.

Following an interim recommendation of the Independent Medicines and Medical Devices Safety Review, the UK government and NHS have paused the use of vaginally inserted surgical mesh.

The government's 11 July 2018 announcement says that the use of vaginally inserted surgical mesh for stress urinary incontinence will be paused until a set of conditions to reduce the risk of injury are met. Vaginally inserted meshes will only be used when there is no alternative and after close and comprehensive consultation between patient and clinician, with rigorous oversight and governance at all times.

It was also recommended that the pause should be extended to include vaginally inserted mesh to treat pelvic organ prolapse, and that the pause should be implemented through a high vigilance regime of restricted practice.

The press release continues "NHS England and NHS Improvement have written to providers to ensure that provider medical directors and nurse directors are equipped with advice and guidance to ensure that clinicians can support patients to make clear decisions about their treatment".

The National Institute for Health and Care Excellence (NICE) said that it will work with NHS England to produce a shared decision making tool, to be available when NICE's guideline on urinary incontinence and pelvic organ prolapse publishes early next year.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

pipette
Synapse

Arbitration for life sciences companies

29 juin 2020
IN-DEPTH ANALYSIS

par plusieurs auteurs

Cliquer ici pour en savoir plus
gloved hand
Responsabilité du fait des produits et de la sécurité des produits

Personal protective equipment COVID-19 export restrictions

23 mars 2020
QUICK READ

par Katie Chandler et Tasmina Goraya, PhD

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

National perspectives on the CJEU Bayer decision

20 février 2020

par plusieurs auteurs

Cliquer ici pour en savoir plus